{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:40:15Z","timestamp":1780580415958,"version":"3.54.1"},"reference-count":19,"publisher":"Impact Journals, LLC","issue":"40","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,15]]},"DOI":"10.18632\/oncotarget.20323","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T17:20:12Z","timestamp":1503076812000},"page":"68890-68898","source":"Crossref","is-referenced-by-count":9,"title":["Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysis"],"prefix":"10.18632","volume":"8","author":[{"given":"Kenji","family":"Omae","sequence":"first","affiliation":[{"name":"Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine\/School of Public Health, Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan"},{"name":"Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima 960-1295, Japan"},{"name":"Department of Urology, Tokyo Women's Medical University, Tokyo 162-8666, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Tsujimoto","sequence":"additional","affiliation":[{"name":"Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine\/School of Public Health, Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michitaka","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Surgery, Southern TOHOKU Research Institute for Neuroscience, Southern TOHOKU General Hospital, 7-115 Yatsuyamada, Koriyama, Fukushima 963-8052, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunenori","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Women's Medical University, Tokyo 162-8666, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Women's Medical University, Tokyo 162-8666, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine\/School of Public Health, Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan"},{"name":"Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima 960-1295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshi A.","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine\/School of Public Health, Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,8,18]]},"reference":[{"key":"1","first-page":"379","article-title":"The skeletal metastatic complications of renal cell carcinoma","volume":"19","author":"Hanock","year":"2001","journal-title":"Int J Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/annonc\/mdr362","article-title":"Distribution of metastatic sites in renal cell carcinoma: a population-based analysis","volume":"23","author":"Karakiewicz","year":"2012","journal-title":"Ann Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.eururo.2014.02.040","article-title":"Prognostic significance of bone metastases and bisphosphonate therapy in patients with renal cell carcinoma","volume":"66","author":"Choueiri","year":"2014","journal-title":"Eur Urol"},{"key":"4","doi-asserted-by":"crossref","first-page":"e000037","DOI":"10.1136\/esmoopen-2016-000037","article-title":"Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, and Japanese Urological Association, and Japanese Society for Radiation Oncology","volume":"1","author":"Kodaira","year":"2016","journal-title":"ESMO Open"},{"key":"5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10147-010-0074-5","article-title":"A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer","volume":"15","author":"Nazmy","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/cncr.11571","article-title":"Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma","volume":"98","author":"Seaman","year":"2003","journal-title":"Cancer"},{"key":"7","unstructured":"Ljungberg, Albiges, Bensalah, Bex, Giles, Hora, Kuczyk, Lam, Marconi, Merseburger, Powles, Staehler, Volpe. Renal cell carcinoma. European Association of Urology. https:\/\/uroweb.org\/guideline\/renal-cell-carcinoma\/. Published 2000. Updated 2016. Accessed June 29, 2017."},{"key":"8","unstructured":"Mottet, Bellmunt, Briers, Bolla, Bourke, Cornford, De Santis, Henry, Joniau, Lam, Mason, van der Poel, van der Kwast, et al. Prostate cancer. European Association of Urology. https:\/\/uroweb.org\/guideline\/prostate-cancer\/. Published 2001. Updated 2016. Accessed June 29, 2017."},{"key":"9","unstructured":"Witjes, Comp\u00e9rat, Cowan, Gakis, Hern\u00e1ndez, Lebret, Lorch, van der Heijden, Ribal. Muscle-invasive and metastatic bladder cancer. European Association of Urology. https:\/\/uroweb.org\/guideline\/bladder-cancer-muscle-invasive-and-metastatic\/. Published 2004. Updated 2016. Accessed June 29, 2017."},{"key":"10","unstructured":"National Cancer Institute. Cancer Therapy Evaluation Program. NIH. http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_40. Published March 2003. Updated November 14, 2016. Accessed May 26, 2017."},{"key":"11","unstructured":"The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Updated March 2011. Available from http:\/\/handbook.cochrane.org\/ Accessed May 26, 2017."},{"key":"12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Sydes","year":"2007","journal-title":"Trials"},{"key":"13","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2535","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"14","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1200\/JCO.2003.04.105","article-title":"Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a Phase III, double-blind, randomized trial","volume":"21","author":"Seaman","year":"2003","journal-title":"J Clin Oncol"},{"key":"15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clgc.2014.07.002","article-title":"Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial","volume":"13","author":"Deva","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"16","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Woll","year":"2011","journal-title":"J Clin Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00520-013-2022-1","article-title":"Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors","volume":"22","author":"Yeh","year":"2014","journal-title":"Support Care Cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"iii124","DOI":"10.1093\/annonc\/mdu103","article-title":"Bone health in cancer patients: ESMO Clinical Practice Guidelines","volume":"25","author":"Herrstedt","year":"2014","journal-title":"Ann Oncol"},{"key":"19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1200\/JCO.1997.15.1.131","article-title":"Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy","volume":"15","author":"Coleman","year":"1997","journal-title":"J Clin Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T16:52:38Z","timestamp":1596732758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,18]]},"references-count":19,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2017,9,15]]}},"alternative-id":["20323","28978165"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.20323","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,18]]}}}